560 related articles for article (PubMed ID: 31029504)
1. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
3. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
5. Impact of donor-specific antibody with low mean fluorescence intensity on allograft outcomes in kidney transplant.
Kitpermkiat R; Kantachuvesiri S; Thotsiri S; Thammanichanond D; Rostaing L; Wiwattanathum P
Transpl Immunol; 2024 Jun; 84():102054. PubMed ID: 38750972
[TBL] [Abstract][Full Text] [Related]
6. Differences in Pathologic Features and Graft Outcomes of Rejection on Kidney Transplant.
Park WY; Paek JH; Jin K; Park SB; Choe M; Han S
Transplant Proc; 2019 Oct; 51(8):2655-2659. PubMed ID: 31345597
[TBL] [Abstract][Full Text] [Related]
7. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
8. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
[TBL] [Abstract][Full Text] [Related]
9. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
10. Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies.
Ulloa CE; Anglicheau D; Snanoudj R; Scemla A; Martinez F; Timsit MO; Legendre C; Sberro-Soussan R
Transplantation; 2019 Oct; 103(10):2150-2156. PubMed ID: 30720681
[TBL] [Abstract][Full Text] [Related]
11. Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
Halleck F; Khadzhynov D; Liefeldt L; Schrezenmeier E; Lehner L; Duerr M; Schmidt D; Bamoulid J; Lachmann N; Waiser J; Budde K; Staeck O
Nephrol Dial Transplant; 2016 Dec; 31(12):2143-2149. PubMed ID: 27369852
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
[TBL] [Abstract][Full Text] [Related]
13. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
14. Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes.
Sousa MV; Zollner RL; Mazzali M
J Bras Nefrol; 2019 Sep; 42(2):201-210. PubMed ID: 31528982
[TBL] [Abstract][Full Text] [Related]
15. Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy.
Schluckebier D; Cousin VL; Petit LM; Belli D; Wildhaber B; Rougemont AL; Villard J; Ferrari-Lacraz S; McLin VA
Pediatr Transplant; 2020 Feb; 24(1):e13611. PubMed ID: 31682057
[TBL] [Abstract][Full Text] [Related]
16. Long-term kidney allograft survival in patients with transplant glomerulitis.
Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
18. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.
Zhao X; Huang G; Randhawa S; Zeng G; Lunz J; Randhawa P
Transplantation; 2017 Feb; 101(2):395-401. PubMed ID: 26901079
[TBL] [Abstract][Full Text] [Related]
19. Acute cellular rejection: impact of donor-specific antibodies and C4d.
Willicombe M; Roufosse C; Brookes P; McLean AG; Galliford J; Cairns T; Cook TH; Taube D
Transplantation; 2014 Feb; 97(4):433-9. PubMed ID: 24430742
[TBL] [Abstract][Full Text] [Related]
20. Antibodies Against ARHGDIB and ARHGDIB Gene Expression Associate With Kidney Allograft Outcome.
Senev A; Otten HG; Kamburova EG; Callemeyn J; Lerut E; Van Sandt V; Kuypers D; Emonds MP; Naesens M
Transplantation; 2020 Jul; 104(7):1462-1471. PubMed ID: 31651716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
